Sign in

Trial result ·

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This phase 2 trial tested exercise and nicotinamide riboside, an NAD+ precursor, in Friedreich's ataxia. People aged 10-40 years took part. It ran for 12 weeks at one site in Philadelphia. It used a 2 × 2 factorial design. Groups got placebo, nicotinamide riboside, exercise, or both. The main goal was change in peak VO2 on an exercise test.

What they found

74 people were enrolled and 66 were randomly assigned. All of them finished the study. The combination raised peak VO2 versus control. Exercise alone and the supplement alone did not clearly differ from control. The combination was not statistically different from exercise alone. Adverse events were all mild or moderate.

What it means for patients

The authors said 12 weeks of nicotinamide riboside plus exercise was safe. They said it raised heart and lung fitness in Friedreich's ataxia, in children and adults. They said longer studies are needed. These would show if adding nicotinamide riboside to exercise could be part of long-term care.

Why it is not certain yet

The combined arm did not clearly beat exercise alone. The trial ran at one site, for 12 weeks. Only 66 people were randomized. Gut symptoms, falls, infections and rashes were reported.

The registered trial

The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.

Source

Safety and efficacy of individualised exercise and NAD+ precursor supplementation in patients with Friedreich's ataxia in the USA: a single-centre, 2 × 2 factorial, randomised controlled trial.

PubMed · PMID 42009009

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Friedreich ataxia publications